Our Blog
The Qualio Blog
Insights on product development, quality management, and regulatory compliance for teams building life-saving products.

What you need to know about FDA 21 CFR Part 211
FDA 21 CFR 211 maps out the operational building blocks of cGMP. Understand what you need for compliance, from lab to manufacturing line.

What you need to know about FDA 21 CFR Part 210
21 CFR 210 compliance is the first step to robust cGMP. Understand what your pharmaceutical or contract manufacturing organization needs in place.

Faster access to your quality landscape with our latest product upgrades
Our latest round of product updates focuses on giving our customers even faster, more intuitive access to their day-to-day quality data. Take a look what we did here.

Ernie Wallerstein, Jr., CEO of Mental Health Technologies
How can technology be used to treat - and even model and predict - mental health? Ernie Wallerstein, CEO of Mental Health Technologies, thinks he has the answer.

Spring in our step at the G2 Spring Awards 2023
We've kicked off 2023 with another haul of G2 awards! Big thanks to our wonderful customers and their reviews.

Guide to GxP compliance: processes, challenges and tools
GxP compliance isn’t optional for life science companies. Review GxP requirements, critical compliance tools and the key facts of GxP compliance.

Top pharmaceutical companies: 5 start-ups to watch in 2024
See our list of the top 5 most exciting pharmaceutical companies landing and expanding in 2023.

Enabling the next generation of biomarker discovery with Dr. Mo Jain, CEO of Sapient
The best lifesaving drugs only work 50% of the time. The reason? Broad-stroke treatments that gloss over the individual variations in our bodies. Dr. Mo Jain's Sapient wants to change all that.

What is cGMP in the pharma industry? 7 experts explain
What is Current Good Manufacturing Practice (cGMP)? Why is it so important for pharma organizations? We interviewed 7 industry experts for the lowdown.